| NCT06643260 | A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy | NOT_YET_RECRUITING | PHASE3 | 2025-06 | 2028-06 | 2027-12 |
| NCT06387342 | Namodenoson Treatment of Advanced Pancreatic Cancer | RECRUITING | PHASE2 | 2024-11-10 | 2026-12-15 | 2026-07-15 |
| NCT05201404 | Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis | RECRUITING | PHASE3 | 2023-03-15 | 2026-10 | 2026-02 |
| NCT04697810 | Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) | RECRUITING | PHASE2 | 2021-12-10 | 2025-10-15 | 2025-04-15 |
| NCT04333472 | Piclidenoson for Treatment of COVID-19 | COMPLETED | PHASE2 | 2021-01-06 | 2022-04-21 | 2022-03-06 |
| NCT01905124 | Safety &Efficacy of CF101 to Subjects With Uveitis | WITHDRAWN | PHASE2 | 2019-01 | 2019-10 | 2019-09 |
| NCT00837291 | A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee | WITHDRAWN | PHASE2 | 2018-11 | 2019-01 | 2018-12 |
| NCT03168256 | CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis | COMPLETED | PHASE3 | 2018-09-15 | 2022-04-27 | 2022-01-06 |
| NCT02927314 | A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease | COMPLETED | PHASE2 | 2017-11-27 | 2020-03-01 | 2020-03-01 |
| NCT02647762 | CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis | TERMINATED | PHASE3 | 2017-10-30 | 2020-11-30 | 2020-11-30 |
| NCT02128958 | Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) | COMPLETED | PHASE2 | 2014-09 | 2021-12-31 | 2017-11-27 |
| NCT01235234 | Trial of CF101 to Treat Patients With Dry Eye Disease | COMPLETED | PHASE3 | 2011-07 | 2013-12 | 2013-11 |
| NCT01265667 | Trial of CF101 to Treat Patients With Psoriasis | COMPLETED | PHASE2, PHASE3 | 2011-07 | 2015-05 | 2015-03 |
| NCT01033422 | Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure | COMPLETED | PHASE2 | 2010-10 | 2017-04 | 2016-12 |
| NCT01034306 | Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis | COMPLETED | PHASE2 | 2010-10 | 2013-12 | 2013-12 |
| NCT00790673 | A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 | COMPLETED | PHASE1, PHASE2 | 2009-07 | 2011-07 | 2011-06 |
| NCT00790218 | A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma | COMPLETED | PHASE1, PHASE2 | 2009-02 | 2013-12 | 2012-12 |
| NCT00556894 | Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients | COMPLETED | PHASE2 | 2008-02 | 2009-04 | 2009-03 |
| NCT00428974 | Safety and Efficacy Study of CF101 to Treat Psoriasis | COMPLETED | PHASE2 | 2007-06 | 2009-09 | 2009-09 |
| NCT00349466 | Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca | COMPLETED | PHASE2 | 2007-01 | 2009-05 | 2009-05 |
| NCT00280917 | Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients | COMPLETED | PHASE2 | 2006-06 | 2007-04 | 2007-04 |